#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1. Introduction
1-1	0-2	1.	_	_	_	_
1-2	3-15	Introduction	abstract	new	_	_

#Text=Poultry production forms an integral part of the economy with many socio-economic and cultural values attached to the birds in most developing countries including Uganda .
2-1	16-23	Poultry	animal|abstract[3]	new|new[3]	coref|coref|coref|coref	3-10|3-9[12_3]|3-10|3-9[12_3]
2-2	24-34	production	abstract[3]	new[3]	_	_
2-3	35-40	forms	_	_	_	_
2-4	41-43	an	_	_	_	_
2-5	44-52	integral	_	_	_	_
2-6	53-57	part	_	_	_	_
2-7	58-60	of	_	_	_	_
2-8	61-64	the	abstract[4]	new[4]	_	_
2-9	65-72	economy	abstract[4]	new[4]	_	_
2-10	73-77	with	abstract[4]	new[4]	_	_
2-11	78-82	many	abstract[4]|abstract[5]	new[4]|new[5]	_	_
2-12	83-97	socio-economic	abstract[4]|abstract[5]	new[4]|new[5]	_	_
2-13	98-101	and	abstract[4]|abstract[5]	new[4]|new[5]	_	_
2-14	102-110	cultural	abstract[4]|abstract[5]	new[4]|new[5]	_	_
2-15	111-117	values	abstract[4]|abstract[5]	new[4]|new[5]	_	_
2-16	118-126	attached	_	_	_	_
2-17	127-129	to	_	_	_	_
2-18	130-133	the	animal[6]	new[6]	coref	5-30[0_6]
2-19	134-139	birds	animal[6]	new[6]	_	_
2-20	140-142	in	_	_	_	_
2-21	143-147	most	place[7]	new[7]	_	_
2-22	148-158	developing	place[7]	new[7]	_	_
2-23	159-168	countries	place[7]	new[7]	_	_
2-24	169-178	including	place[7]	new[7]	_	_
2-25	179-185	Uganda	place[7]|place	new[7]|new	coref	31-51
2-26	186-187	.	_	_	_	_

#Text=However , one of the major challenges to improved poultry production is the prevalence of poultry diseases that threaten the intensification of production .
3-1	188-195	However	_	_	_	_
3-2	196-197	,	_	_	_	_
3-3	198-201	one	abstract[9]	new[9]	coref	3-13[13_9]
3-4	202-204	of	abstract[9]	new[9]	_	_
3-5	205-208	the	abstract[9]|abstract[10]	new[9]|new[10]	_	_
3-6	209-214	major	abstract[9]|abstract[10]	new[9]|new[10]	_	_
3-7	215-225	challenges	abstract[9]|abstract[10]	new[9]|new[10]	_	_
3-8	226-228	to	abstract[9]|abstract[10]	new[9]|new[10]	_	_
3-9	229-237	improved	abstract[9]|abstract[10]|abstract[12]	new[9]|new[10]|giv[12]	coref	3-23[0_12]
3-10	238-245	poultry	abstract[9]|abstract[10]|animal|abstract[12]	new[9]|new[10]|giv|giv[12]	coref	3-16
3-11	246-256	production	abstract[9]|abstract[10]|abstract[12]	new[9]|new[10]|giv[12]	_	_
3-12	257-259	is	_	_	_	_
3-13	260-263	the	abstract[13]	giv[13]	_	_
3-14	264-274	prevalence	abstract[13]	giv[13]	_	_
3-15	275-277	of	abstract[13]	giv[13]	_	_
3-16	278-285	poultry	abstract[13]|animal|abstract[15]	giv[13]|giv|new[15]	coref|coref|coref|coref	4-4[18_15]|10-9[66_0]|4-4[18_15]|10-9[66_0]
3-17	286-294	diseases	abstract[13]|abstract[15]	giv[13]|new[15]	_	_
3-18	295-299	that	_	_	_	_
3-19	300-308	threaten	_	_	_	_
3-20	309-312	the	abstract[16]	new[16]	_	_
3-21	313-328	intensification	abstract[16]	new[16]	_	_
3-22	329-331	of	abstract[16]	new[16]	_	_
3-23	332-342	production	abstract[16]|abstract	new[16]|giv	coref	7-9[39_0]
3-24	343-344	.	_	_	_	_

#Text=Among these are gastrointestinal parasitic diseases notably , coccidiosis .
4-1	345-350	Among	_	_	_	_
4-2	351-356	these	_	_	_	_
4-3	357-360	are	_	_	_	_
4-4	361-377	gastrointestinal	abstract[18]	giv[18]	_	_
4-5	378-387	parasitic	abstract[18]	giv[18]	_	_
4-6	388-396	diseases	abstract[18]	giv[18]	_	_
4-7	397-404	notably	abstract[19]	new[19]	coref	5-1[0_19]
4-8	405-406	,	abstract[19]	new[19]	_	_
4-9	407-418	coccidiosis	abstract[19]	new[19]	_	_
4-10	419-420	.	_	_	_	_

#Text=Coccidiosis is a disease caused by parasites of the genus Eimeria and phylum Apicomplexa with a complex life cycle , affecting mainly the intestinal tract of many species of birds .
5-1	421-432	Coccidiosis	abstract	giv	coref	5-3[21_0]
5-2	433-435	is	_	_	_	_
5-3	436-437	a	abstract[21]	giv[21]	coref	7-5[0_21]
5-4	438-445	disease	abstract[21]	giv[21]	_	_
5-5	446-452	caused	_	_	_	_
5-6	453-455	by	_	_	_	_
5-7	456-465	parasites	animal[22]	new[22]	_	_
5-8	466-468	of	animal[22]	new[22]	_	_
5-9	469-472	the	animal[22]	new[22]	_	_
5-10	473-478	genus	animal[22]|abstract	new[22]|new	_	_
5-11	479-486	Eimeria	animal[22]	new[22]	_	_
5-12	487-490	and	animal[22]	new[22]	_	_
5-13	491-497	phylum	animal[22]|person|animal[25]	new[22]|new|new[25]	_	_
5-14	498-509	Apicomplexa	animal[22]|animal[25]	new[22]|new[25]	_	_
5-15	510-514	with	animal[22]	new[22]	_	_
5-16	515-516	a	animal[22]|abstract[27]	new[22]|new[27]	ana	6-1[0_27]
5-17	517-524	complex	animal[22]|abstract[27]	new[22]|new[27]	_	_
5-18	525-529	life	animal[22]|abstract|abstract[27]	new[22]|new|new[27]	coref	8-12
5-19	530-535	cycle	animal[22]|abstract[27]	new[22]|new[27]	_	_
5-20	536-537	,	_	_	_	_
5-21	538-547	affecting	_	_	_	_
5-22	548-554	mainly	_	_	_	_
5-23	555-558	the	object[28]	new[28]	_	_
5-24	559-569	intestinal	object[28]	new[28]	_	_
5-25	570-575	tract	object[28]	new[28]	_	_
5-26	576-578	of	object[28]	new[28]	_	_
5-27	579-583	many	object[28]|animal[29]	new[28]|new[29]	coref	13-6[91_29]
5-28	584-591	species	object[28]|animal[29]	new[28]|new[29]	_	_
5-29	592-594	of	object[28]|animal[29]	new[28]|new[29]	_	_
5-30	595-600	birds	object[28]|animal[29]|animal	new[28]|new[29]|giv	_	_
5-31	601-602	.	_	_	_	_

#Text=It is of great economic significance in farm animals , especially chickens .
6-1	603-605	It	abstract	giv	coref	8-11[52_0]
6-2	606-608	is	_	_	_	_
6-3	609-611	of	_	_	_	_
6-4	612-617	great	abstract[32]	new[32]	coref	7-1[36_32]
6-5	618-626	economic	abstract[32]	new[32]	_	_
6-6	627-639	significance	abstract[32]	new[32]	_	_
6-7	640-642	in	abstract[32]	new[32]	_	_
6-8	643-647	farm	abstract[32]|place|animal[34]	new[32]|new|new[34]	coref|coref|coref|coref	16-12[125_0]|17-5[0_34]|16-12[125_0]|17-5[0_34]
6-9	648-655	animals	abstract[32]|animal[34]	new[32]|new[34]	_	_
6-10	656-657	,	_	_	_	_
6-11	658-668	especially	animal[35]	new[35]	coref	13-37[0_35]
6-12	669-677	chickens	animal[35]	new[35]	_	_
6-13	678-679	.	_	_	_	_

#Text=The economic significance of coccidiosis is attributed to decreased animal production in terms of poor feed conversion , growth depression and increased mortality ; and the costs involved in treatment and prevention .
7-1	680-683	The	abstract[36]	giv[36]	_	_
7-2	684-692	economic	abstract[36]	giv[36]	_	_
7-3	693-705	significance	abstract[36]	giv[36]	_	_
7-4	706-708	of	abstract[36]	giv[36]	_	_
7-5	709-720	coccidiosis	abstract[36]|abstract	giv[36]|giv	coref	10-7
7-6	721-723	is	_	_	_	_
7-7	724-734	attributed	_	_	_	_
7-8	735-737	to	_	_	_	_
7-9	738-747	decreased	abstract[39]	giv[39]	coref	19-39[0_39]
7-10	748-754	animal	animal|abstract[39]	new|giv[39]	coref	14-15
7-11	755-765	production	abstract[39]	giv[39]	_	_
7-12	766-768	in	_	_	_	_
7-13	769-774	terms	_	_	_	_
7-14	775-777	of	_	_	_	_
7-15	778-782	poor	event[41]	new[41]	_	_
7-16	783-787	feed	substance|event[41]	new|new[41]	coref	11-11
7-17	788-798	conversion	event[41]	new[41]	_	_
7-18	799-800	,	_	_	_	_
7-19	801-807	growth	abstract|abstract[43]	new|new[43]	coref|coref	11-19[73_0]|11-19[73_0]
7-20	808-818	depression	abstract[43]	new[43]	_	_
7-21	819-822	and	_	_	_	_
7-22	823-832	increased	event[44]	new[44]	_	_
7-23	833-842	mortality	event[44]	new[44]	_	_
7-24	843-844	;	_	_	_	_
7-25	845-848	and	_	_	_	_
7-26	849-852	the	abstract[45]	new[45]	coref	10-1[64_45]
7-27	853-858	costs	abstract[45]	new[45]	_	_
7-28	859-867	involved	_	_	_	_
7-29	868-870	in	_	_	_	_
7-30	871-880	treatment	abstract	new	_	_
7-31	881-884	and	_	_	_	_
7-32	885-895	prevention	abstract	new	_	_
7-33	896-897	.	_	_	_	_

#Text=Pathogenesis entails Eimeria invading the intestinal cells as part of the life cycle .
8-1	898-910	Pathogenesis	abstract	new	_	_
8-2	911-918	entails	_	_	_	_
8-3	919-926	Eimeria	animal	new	coref	13-7
8-4	927-935	invading	_	_	_	_
8-5	936-939	the	place[50]	new[50]	_	_
8-6	940-950	intestinal	place[50]	new[50]	_	_
8-7	951-956	cells	place[50]	new[50]	_	_
8-8	957-959	as	_	_	_	_
8-9	960-964	part	_	_	_	_
8-10	965-967	of	_	_	_	_
8-11	968-971	the	abstract[52]	giv[52]	_	_
8-12	972-976	life	abstract|abstract[52]	giv|giv[52]	_	_
8-13	977-982	cycle	abstract[52]	giv[52]	_	_
8-14	983-984	.	_	_	_	_

#Text=The resulting intestinal damage impairs nutrients digestion and absorption , gut barrier function , and ultimately leads to bacterial infections particularly necrotic enteritis .
9-1	985-988	The	abstract[53]	new[53]	_	_
9-2	989-998	resulting	abstract[53]	new[53]	_	_
9-3	999-1009	intestinal	abstract[53]	new[53]	_	_
9-4	1010-1016	damage	abstract[53]	new[53]	_	_
9-5	1017-1024	impairs	_	_	_	_
9-6	1025-1034	nutrients	substance|substance[55]	new|new[55]	_	_
9-7	1035-1044	digestion	substance[55]	new[55]	_	_
9-8	1045-1048	and	_	_	_	_
9-9	1049-1059	absorption	abstract	new	_	_
9-10	1060-1061	,	_	_	_	_
9-11	1062-1065	gut	abstract|abstract[59]	new|new[59]	coref|coref	18-15|18-15
9-12	1066-1073	barrier	object|abstract[59]	new|new[59]	_	_
9-13	1074-1082	function	abstract[59]	new[59]	_	_
9-14	1083-1084	,	_	_	_	_
9-15	1085-1088	and	_	_	_	_
9-16	1089-1099	ultimately	_	_	_	_
9-17	1100-1105	leads	_	_	_	_
9-18	1106-1108	to	_	_	_	_
9-19	1109-1118	bacterial	object|abstract[61]	new|new[61]	coref|coref|coref|coref	13-21|13-20[96_61]|13-21|13-20[96_61]
9-20	1119-1129	infections	abstract[61]	new[61]	_	_
9-21	1130-1142	particularly	object[62]	new[62]	_	_
9-22	1143-1151	necrotic	object[62]	new[62]	_	_
9-23	1152-1161	enteritis	object[62]	new[62]	_	_
9-24	1162-1163	.	_	_	_	_

#Text=The global annual costs inflicted by coccidiosis to commercial poultry have been estimated at 2 billion â‚¬ .
10-1	1164-1167	The	abstract[64]	giv[64]	_	_
10-2	1168-1174	global	abstract[64]	giv[64]	_	_
10-3	1175-1181	annual	time|abstract[64]	new|giv[64]	_	_
10-4	1182-1187	costs	abstract[64]	giv[64]	_	_
10-5	1188-1197	inflicted	_	_	_	_
10-6	1198-1200	by	_	_	_	_
10-7	1201-1212	coccidiosis	abstract	giv	coref	12-20
10-8	1213-1215	to	_	_	_	_
10-9	1216-1226	commercial	animal[66]	giv[66]	coref	11-23[0_66]
10-10	1227-1234	poultry	animal[66]	giv[66]	_	_
10-11	1235-1239	have	_	_	_	_
10-12	1240-1244	been	_	_	_	_
10-13	1245-1254	estimated	_	_	_	_
10-14	1255-1257	at	_	_	_	_
10-15	1258-1259	2	quantity[67]	new[67]	_	_
10-16	1260-1267	billion	quantity[67]	new[67]	_	_
10-17	1268-1269	â‚¬	_	_	_	_
10-18	1270-1271	.	_	_	_	_

#Text=For the past 5 decades , the use of anti-coccidial feed additives has played a major role in the growth of the poultry industry facilitating increased availability of quality and affordable poultry products to the consumers .
11-1	1272-1275	For	_	_	_	_
11-2	1276-1279	the	time[68]	new[68]	coref	18-3[137_68]
11-3	1280-1284	past	time[68]	new[68]	_	_
11-4	1285-1286	5	time[68]	new[68]	_	_
11-5	1287-1294	decades	time[68]	new[68]	_	_
11-6	1295-1296	,	_	_	_	_
11-7	1297-1300	the	abstract[69]	new[69]	_	_
11-8	1301-1304	use	abstract[69]	new[69]	_	_
11-9	1305-1307	of	abstract[69]	new[69]	_	_
11-10	1308-1322	anti-coccidial	abstract[69]|abstract[71]	new[69]|new[71]	_	_
11-11	1323-1327	feed	abstract[69]|substance|abstract[71]	new[69]|giv|new[71]	_	_
11-12	1328-1337	additives	abstract[69]|abstract[71]	new[69]|new[71]	_	_
11-13	1338-1341	has	_	_	_	_
11-14	1342-1348	played	_	_	_	_
11-15	1349-1350	a	abstract[72]	new[72]	_	_
11-16	1351-1356	major	abstract[72]	new[72]	_	_
11-17	1357-1361	role	abstract[72]	new[72]	_	_
11-18	1362-1364	in	abstract[72]	new[72]	_	_
11-19	1365-1368	the	abstract[72]|abstract[73]	new[72]|giv[73]	coref	20-34[0_73]
11-20	1369-1375	growth	abstract[72]|abstract[73]	new[72]|giv[73]	_	_
11-21	1376-1378	of	abstract[72]|abstract[73]	new[72]|giv[73]	_	_
11-22	1379-1382	the	abstract[72]|abstract[73]|abstract[75]	new[72]|giv[73]|new[75]	_	_
11-23	1383-1390	poultry	abstract[72]|abstract[73]|animal|abstract[75]	new[72]|giv[73]|giv|new[75]	coref	11-32
11-24	1391-1399	industry	abstract[72]|abstract[73]|abstract[75]	new[72]|giv[73]|new[75]	_	_
11-25	1400-1412	facilitating	_	_	_	_
11-26	1413-1422	increased	event[76]	new[76]	_	_
11-27	1423-1435	availability	event[76]	new[76]	_	_
11-28	1436-1438	of	event[76]	new[76]	_	_
11-29	1439-1446	quality	event[76]|abstract	new[76]|new	coref	28-27[240_0]
11-30	1447-1450	and	event[76]	new[76]	_	_
11-31	1451-1461	affordable	event[76]|object[79]	new[76]|new[79]	coref	14-15[108_79]
11-32	1462-1469	poultry	event[76]|animal|object[79]	new[76]|giv|new[79]	coref	15-21
11-33	1470-1478	products	event[76]|object[79]	new[76]|new[79]	_	_
11-34	1479-1481	to	event[76]|object[79]	new[76]|new[79]	_	_
11-35	1482-1485	the	event[76]|object[79]|person[80]	new[76]|new[79]|new[80]	_	_
11-36	1486-1495	consumers	event[76]|object[79]|person[80]	new[76]|new[79]|new[80]	_	_
11-37	1496-1497	.	_	_	_	_

#Text=However , some degree of resistance to all anticoccidial drugs , including ionophores which are now the mainstay of coccidiosis control has been reported .
12-1	1498-1505	However	_	_	_	_
12-2	1506-1507	,	_	_	_	_
12-3	1508-1512	some	abstract[81]	new[81]	_	_
12-4	1513-1519	degree	abstract[81]	new[81]	_	_
12-5	1520-1522	of	abstract[81]	new[81]	_	_
12-6	1523-1533	resistance	abstract[81]|abstract[82]	new[81]|new[82]	coref	15-17[119_82]
12-7	1534-1536	to	abstract[81]|abstract[82]	new[81]|new[82]	_	_
12-8	1537-1540	all	abstract[81]|abstract[82]|substance[83]	new[81]|new[82]|new[83]	coref	13-11[92_83]
12-9	1541-1554	anticoccidial	abstract[81]|abstract[82]|substance[83]	new[81]|new[82]|new[83]	_	_
12-10	1555-1560	drugs	abstract[81]|abstract[82]|substance[83]	new[81]|new[82]|new[83]	_	_
12-11	1561-1562	,	abstract[81]	new[81]	_	_
12-12	1563-1572	including	abstract[81]	new[81]	_	_
12-13	1573-1583	ionophores	abstract[81]|substance	new[81]|new	_	_
12-14	1584-1589	which	_	_	_	_
12-15	1590-1593	are	_	_	_	_
12-16	1594-1597	now	abstract[85]	new[85]	_	_
12-17	1598-1601	the	abstract[85]	new[85]	_	_
12-18	1602-1610	mainstay	abstract[85]	new[85]	_	_
12-19	1611-1613	of	abstract[85]	new[85]	_	_
12-20	1614-1625	coccidiosis	abstract[85]|abstract|abstract[87]	new[85]|giv|new[87]	coref|coref|coref|coref	14-27[112_87]|15-3|14-27[112_87]|15-3
12-21	1626-1633	control	abstract[85]|abstract[87]	new[85]|new[87]	_	_
12-22	1634-1637	has	_	_	_	_
12-23	1638-1642	been	_	_	_	_
12-24	1643-1651	reported	_	_	_	_
12-25	1652-1653	.	_	_	_	_

#Text=Concerns over the development of resistant Eimeria species to existing anticoccidial drugs and restrictive use of antibiotics to control secondary bacterial infections further stresses the urgent need to explore alternative strategies for maintaining intestinal functionality in chickens .
13-1	1654-1662	Concerns	abstract[88]	new[88]	coref	14-8[104_88]
13-2	1663-1667	over	abstract[88]	new[88]	_	_
13-3	1668-1671	the	abstract[88]|event[89]	new[88]|new[89]	_	_
13-4	1672-1683	development	abstract[88]|event[89]	new[88]|new[89]	_	_
13-5	1684-1686	of	abstract[88]|event[89]	new[88]|new[89]	_	_
13-6	1687-1696	resistant	abstract[88]|event[89]|animal[91]	new[88]|new[89]|giv[91]	_	_
13-7	1697-1704	Eimeria	abstract[88]|event[89]|animal|animal[91]	new[88]|new[89]|giv|giv[91]	_	_
13-8	1705-1712	species	abstract[88]|event[89]|animal[91]	new[88]|new[89]|giv[91]	_	_
13-9	1713-1715	to	_	_	_	_
13-10	1716-1724	existing	_	_	_	_
13-11	1725-1738	anticoccidial	substance[92]	giv[92]	_	_
13-12	1739-1744	drugs	substance[92]	giv[92]	_	_
13-13	1745-1748	and	substance[92]	giv[92]	_	_
13-14	1749-1760	restrictive	substance[92]|abstract[93]	giv[92]|new[93]	_	_
13-15	1761-1764	use	substance[92]|abstract[93]	giv[92]|new[93]	_	_
13-16	1765-1767	of	substance[92]|abstract[93]	giv[92]|new[93]	_	_
13-17	1768-1779	antibiotics	substance[92]|abstract[93]|object	giv[92]|new[93]|new	coref	19-4[145_0]
13-18	1780-1782	to	_	_	_	_
13-19	1783-1790	control	_	_	_	_
13-20	1791-1800	secondary	abstract[96]	giv[96]	_	_
13-21	1801-1810	bacterial	object|abstract[96]	giv|giv[96]	_	_
13-22	1811-1821	infections	abstract[96]	giv[96]	_	_
13-23	1822-1829	further	_	_	_	_
13-24	1830-1838	stresses	_	_	_	_
13-25	1839-1842	the	abstract[97]	new[97]	coref	14-18[109_97]
13-26	1843-1849	urgent	abstract[97]	new[97]	_	_
13-27	1850-1854	need	abstract[97]	new[97]	_	_
13-28	1855-1857	to	_	_	_	_
13-29	1858-1865	explore	_	_	_	_
13-30	1866-1877	alternative	abstract[98]	new[98]	coref	14-24[111_98]
13-31	1878-1888	strategies	abstract[98]	new[98]	_	_
13-32	1889-1892	for	_	_	_	_
13-33	1893-1904	maintaining	_	_	_	_
13-34	1905-1915	intestinal	abstract[99]	new[99]	_	_
13-35	1916-1929	functionality	abstract[99]	new[99]	_	_
13-36	1930-1932	in	_	_	_	_
13-37	1933-1941	chickens	animal	giv	coref	18-18
13-38	1942-1943	.	_	_	_	_

#Text=In addition , serious public health and food safety concerns regarding drug residues in animal products highlight the need for researchers to develop alternative strategies for the control of parasitic problems .
14-1	1944-1946	In	_	_	_	_
14-2	1947-1955	addition	_	_	_	_
14-3	1956-1957	,	_	_	_	_
14-4	1958-1965	serious	abstract[101]	new[101]	coref	31-31[271_101]
14-5	1966-1972	public	abstract[101]	new[101]	_	_
14-6	1973-1979	health	abstract[101]	new[101]	_	_
14-7	1980-1983	and	_	_	_	_
14-8	1984-1988	food	substance|abstract[104]	new|giv[104]	_	_
14-9	1989-1995	safety	abstract|abstract[104]	new|giv[104]	_	_
14-10	1996-2004	concerns	abstract[104]	giv[104]	_	_
14-11	2005-2014	regarding	_	_	_	_
14-12	2015-2019	drug	substance|substance[106]	new|new[106]	coref|coref	15-18|15-18
14-13	2020-2028	residues	substance[106]	new[106]	_	_
14-14	2029-2031	in	substance[106]	new[106]	_	_
14-15	2032-2038	animal	substance[106]|animal|object[108]	new[106]|giv|giv[108]	_	_
14-16	2039-2047	products	substance[106]|object[108]	new[106]|giv[108]	_	_
14-17	2048-2057	highlight	_	_	_	_
14-18	2058-2061	the	abstract[109]	giv[109]	_	_
14-19	2062-2066	need	abstract[109]	giv[109]	_	_
14-20	2067-2070	for	abstract[109]	giv[109]	_	_
14-21	2071-2082	researchers	abstract[109]|person	giv[109]|new	_	_
14-22	2083-2085	to	_	_	_	_
14-23	2086-2093	develop	_	_	_	_
14-24	2094-2105	alternative	abstract[111]	giv[111]	coref	16-8[124_111]
14-25	2106-2116	strategies	abstract[111]	giv[111]	_	_
14-26	2117-2120	for	_	_	_	_
14-27	2121-2124	the	abstract[112]	giv[112]	coref	15-12[117_112]
14-28	2125-2132	control	abstract[112]	giv[112]	_	_
14-29	2133-2135	of	abstract[112]	giv[112]	_	_
14-30	2136-2145	parasitic	abstract[112]|abstract[113]	giv[112]|new[113]	_	_
14-31	2146-2154	problems	abstract[112]|abstract[113]	giv[112]|new[113]	_	_
14-32	2155-2156	.	_	_	_	_

#Text=Vaccines for coccidiosis have been reported as an effective tool for disease control and to ameliorate anticoccidial drug resistance in poultry .
15-1	2157-2165	Vaccines	abstract[114]	new[114]	ana	16-3[0_114]
15-2	2166-2169	for	abstract[114]	new[114]	_	_
15-3	2170-2181	coccidiosis	abstract[114]|abstract	new[114]|giv	coref	15-12
15-4	2182-2186	have	_	_	_	_
15-5	2187-2191	been	_	_	_	_
15-6	2192-2200	reported	_	_	_	_
15-7	2201-2203	as	_	_	_	_
15-8	2204-2206	an	_	_	_	_
15-9	2207-2216	effective	_	_	_	_
15-10	2217-2221	tool	_	_	_	_
15-11	2222-2225	for	_	_	_	_
15-12	2226-2233	disease	abstract|abstract[117]	giv|giv[117]	coref|coref	20-31|20-31
15-13	2234-2241	control	abstract[117]	giv[117]	_	_
15-14	2242-2245	and	_	_	_	_
15-15	2246-2248	to	_	_	_	_
15-16	2249-2259	ameliorate	_	_	_	_
15-17	2260-2273	anticoccidial	abstract[119]	giv[119]	_	_
15-18	2274-2278	drug	substance|abstract[119]	giv|giv[119]	_	_
15-19	2279-2289	resistance	abstract[119]	giv[119]	_	_
15-20	2290-2292	in	abstract[119]	giv[119]	_	_
15-21	2293-2300	poultry	abstract[119]|animal	giv[119]|giv	coref	19-38
15-22	2301-2302	.	_	_	_	_

#Text=However , their efficacy depends greatly on the management strategies in a farm .
16-1	2303-2310	However	_	_	_	_
16-2	2311-2312	,	_	_	_	_
16-3	2313-2318	their	abstract|abstract[122]	giv|new[122]	ana|coref|ana|coref	20-29|29-3[241_122]|20-29|29-3[241_122]
16-4	2319-2327	efficacy	abstract[122]	new[122]	_	_
16-5	2328-2335	depends	_	_	_	_
16-6	2336-2343	greatly	_	_	_	_
16-7	2344-2346	on	_	_	_	_
16-8	2347-2350	the	abstract[124]	giv[124]	_	_
16-9	2351-2361	management	person|abstract[124]	new|giv[124]	_	_
16-10	2362-2372	strategies	abstract[124]	giv[124]	_	_
16-11	2373-2375	in	abstract[124]	giv[124]	_	_
16-12	2376-2377	a	abstract[124]|place[125]	giv[124]|giv[125]	_	_
16-13	2378-2382	farm	abstract[124]|place[125]	giv[124]|giv[125]	_	_
16-14	2383-2384	.	_	_	_	_

#Text=The digestive tract of animals harbors a great number of living and metabolizing microorganisms ( microbiota ) , that not only influence physiological functions of the host , but are also considered fundamental for a proper development of several vital traits , including immune system .
17-1	2385-2388	The	object[126]	new[126]	_	_
17-2	2389-2398	digestive	object[126]	new[126]	_	_
17-3	2399-2404	tract	object[126]	new[126]	_	_
17-4	2405-2407	of	object[126]	new[126]	_	_
17-5	2408-2415	animals	object[126]|animal	new[126]|giv	coref	19-26
17-6	2416-2423	harbors	_	_	_	_
17-7	2424-2425	a	abstract[128]	new[128]	_	_
17-8	2426-2431	great	abstract[128]	new[128]	_	_
17-9	2432-2438	number	abstract[128]	new[128]	_	_
17-10	2439-2441	of	abstract[128]	new[128]	_	_
17-11	2442-2448	living	abstract[128]	new[128]	_	_
17-12	2449-2452	and	abstract[128]	new[128]	_	_
17-13	2453-2465	metabolizing	abstract[128]|animal[129]	new[128]|new[129]	appos	17-16[0_129]
17-14	2466-2480	microorganisms	abstract[128]|animal[129]	new[128]|new[129]	_	_
17-15	2481-2482	(	_	_	_	_
17-16	2483-2493	microbiota	animal	giv	_	_
17-17	2494-2495	)	_	_	_	_
17-18	2496-2497	,	_	_	_	_
17-19	2498-2502	that	_	_	_	_
17-20	2503-2506	not	_	_	_	_
17-21	2507-2511	only	_	_	_	_
17-22	2512-2521	influence	_	_	_	_
17-23	2522-2535	physiological	abstract[131]	new[131]	_	_
17-24	2536-2545	functions	abstract[131]	new[131]	_	_
17-25	2546-2548	of	abstract[131]	new[131]	_	_
17-26	2549-2552	the	abstract[131]|animal[132]	new[131]|new[132]	coref	28-18[236_132]
17-27	2553-2557	host	abstract[131]|animal[132]	new[131]|new[132]	_	_
17-28	2558-2559	,	_	_	_	_
17-29	2560-2563	but	_	_	_	_
17-30	2564-2567	are	_	_	_	_
17-31	2568-2572	also	_	_	_	_
17-32	2573-2583	considered	_	_	_	_
17-33	2584-2595	fundamental	_	_	_	_
17-34	2596-2599	for	_	_	_	_
17-35	2600-2601	a	event[133]	new[133]	_	_
17-36	2602-2608	proper	event[133]	new[133]	_	_
17-37	2609-2620	development	event[133]	new[133]	_	_
17-38	2621-2623	of	event[133]	new[133]	_	_
17-39	2624-2631	several	event[133]|abstract[134]	new[133]|new[134]	coref	31-24[267_134]
17-40	2632-2637	vital	event[133]|abstract[134]	new[133]|new[134]	_	_
17-41	2638-2644	traits	event[133]|abstract[134]	new[133]|new[134]	_	_
17-42	2645-2646	,	event[133]|abstract[134]	new[133]|new[134]	_	_
17-43	2647-2656	including	event[133]|abstract[134]	new[133]|new[134]	_	_
17-44	2657-2663	immune	event[133]|abstract[134]|abstract|abstract[136]	new[133]|new[134]|new|new[136]	coref|coref|coref|coref	20-20|20-18[165_136]|20-20|20-18[165_136]
17-45	2664-2670	system	event[133]|abstract[134]|abstract[136]	new[133]|new[134]|new[136]	_	_
17-46	2671-2672	.	_	_	_	_

#Text=Thus , the past decades , have seen much effort going into optimizing the gut microbiota of chickens using dietary interventions .
18-1	2673-2677	Thus	_	_	_	_
18-2	2678-2679	,	_	_	_	_
18-3	2680-2683	the	time[137]	giv[137]	_	_
18-4	2684-2688	past	time[137]	giv[137]	_	_
18-5	2689-2696	decades	time[137]	giv[137]	_	_
18-6	2697-2698	,	_	_	_	_
18-7	2699-2703	have	_	_	_	_
18-8	2704-2708	seen	_	_	_	_
18-9	2709-2713	much	abstract[138]	new[138]	_	_
18-10	2714-2720	effort	abstract[138]	new[138]	_	_
18-11	2721-2726	going	_	_	_	_
18-12	2727-2731	into	_	_	_	_
18-13	2732-2742	optimizing	_	_	_	_
18-14	2743-2746	the	abstract[140]	new[140]	coref	27-34[229_140]
18-15	2747-2750	gut	abstract|abstract[140]	giv|new[140]	coref	31-31
18-16	2751-2761	microbiota	abstract[140]	new[140]	_	_
18-17	2762-2764	of	abstract[140]	new[140]	_	_
18-18	2765-2773	chickens	abstract[140]|animal	new[140]|giv	coref	24-9
18-19	2774-2779	using	_	_	_	_
18-20	2780-2787	dietary	abstract|abstract[143]	new|new[143]	_	_
18-21	2788-2801	interventions	abstract[143]	new[143]	_	_
18-22	2802-2803	.	_	_	_	_

#Text=Although use of antibiotics at subtherapeutic levels has been the most popular and perhaps the most effective strategy to enhance feed efficiency and to keep animals healthy , the approach is no longer a feasible tool for poultry production performance enhancement due to its ban by the EU in 2006 .
19-1	2804-2812	Although	_	_	_	_
19-2	2813-2816	use	abstract[144]	new[144]	_	_
19-3	2817-2819	of	abstract[144]	new[144]	_	_
19-4	2820-2831	antibiotics	abstract[144]|object[145]	new[144]|giv[145]	coref	20-41[0_145]
19-5	2832-2834	at	abstract[144]|object[145]	new[144]|giv[145]	_	_
19-6	2835-2849	subtherapeutic	abstract[144]|object[145]|abstract[146]	new[144]|giv[145]|new[146]	_	_
19-7	2850-2856	levels	abstract[144]|object[145]|abstract[146]	new[144]|giv[145]|new[146]	_	_
19-8	2857-2860	has	_	_	_	_
19-9	2861-2865	been	_	_	_	_
19-10	2866-2869	the	abstract[147]	new[147]	_	_
19-11	2870-2874	most	abstract[147]	new[147]	_	_
19-12	2875-2882	popular	abstract[147]	new[147]	_	_
19-13	2883-2886	and	abstract[147]	new[147]	_	_
19-14	2887-2894	perhaps	abstract[147]	new[147]	_	_
19-15	2895-2898	the	abstract[147]	new[147]	_	_
19-16	2899-2903	most	abstract[147]	new[147]	_	_
19-17	2904-2913	effective	abstract[147]	new[147]	_	_
19-18	2914-2922	strategy	abstract[147]	new[147]	_	_
19-19	2923-2925	to	_	_	_	_
19-20	2926-2933	enhance	_	_	_	_
19-21	2934-2938	feed	_	_	_	_
19-22	2939-2949	efficiency	abstract	new	_	_
19-23	2950-2953	and	_	_	_	_
19-24	2954-2956	to	_	_	_	_
19-25	2957-2961	keep	_	_	_	_
19-26	2962-2969	animals	animal	giv	coref	23-17[186_0]
19-27	2970-2977	healthy	_	_	_	_
19-28	2978-2979	,	_	_	_	_
19-29	2980-2983	the	abstract[150]	new[150]	coref	19-33[151_150]
19-30	2984-2992	approach	abstract[150]	new[150]	_	_
19-31	2993-2995	is	_	_	_	_
19-32	2996-2998	no	_	_	_	_
19-33	2999-3005	longer	abstract[151]	giv[151]	_	_
19-34	3006-3007	a	abstract[151]	giv[151]	_	_
19-35	3008-3016	feasible	abstract[151]	giv[151]	_	_
19-36	3017-3021	tool	abstract[151]	giv[151]	_	_
19-37	3022-3025	for	abstract[151]	giv[151]	_	_
19-38	3026-3033	poultry	abstract[151]|animal|abstract[155]	giv[151]|giv|new[155]	ana|ana	19-44[0_155]|19-44[0_155]
19-39	3034-3044	production	abstract[151]|abstract|abstract[155]	giv[151]|giv|new[155]	_	_
19-40	3045-3056	performance	abstract[151]|abstract|abstract[155]	giv[151]|new|new[155]	coref	20-34[170_0]
19-41	3057-3068	enhancement	abstract[151]|abstract[155]	giv[151]|new[155]	_	_
19-42	3069-3072	due	_	_	_	_
19-43	3073-3075	to	_	_	_	_
19-44	3076-3079	its	abstract|event[157]	giv|new[157]	_	_
19-45	3080-3083	ban	event[157]	new[157]	_	_
19-46	3084-3086	by	event[157]	new[157]	_	_
19-47	3087-3090	the	event[157]|place[158]	new[157]|new[158]	_	_
19-48	3091-3093	EU	event[157]|place[158]	new[157]|new[158]	_	_
19-49	3094-3096	in	event[157]	new[157]	_	_
19-50	3097-3101	2006	event[157]|time	new[157]|new	_	_
19-51	3102-3103	.	_	_	_	_

#Text=Incorporation of immunobiotics , particularly lactic acid bacteria is thought to be useful as immunomodulators to stimulate the gut-associated immune system in neonatal chicks , and thereby protect them from disease without decreasing growth performance as a possible substitution of antibiotics .
20-1	3104-3117	Incorporation	abstract[160]	new[160]	_	_
20-2	3118-3120	of	abstract[160]	new[160]	_	_
20-3	3121-3134	immunobiotics	abstract[160]|substance	new[160]|new	_	_
20-4	3135-3136	,	abstract[160]	new[160]	_	_
20-5	3137-3149	particularly	abstract[160]|abstract[162]|substance[163]	new[160]|new[162]|new[163]	_	_
20-6	3150-3156	lactic	abstract[160]|abstract[162]|substance[163]	new[160]|new[162]|new[163]	_	_
20-7	3157-3161	acid	abstract[160]|substance[163]	new[160]|new[163]	_	_
20-8	3162-3170	bacteria	abstract[160]|substance[163]	new[160]|new[163]	_	_
20-9	3171-3173	is	_	_	_	_
20-10	3174-3181	thought	_	_	_	_
20-11	3182-3184	to	_	_	_	_
20-12	3185-3187	be	_	_	_	_
20-13	3188-3194	useful	_	_	_	_
20-14	3195-3197	as	_	_	_	_
20-15	3198-3214	immunomodulators	_	_	_	_
20-16	3215-3217	to	_	_	_	_
20-17	3218-3227	stimulate	_	_	_	_
20-18	3228-3231	the	abstract[165]	giv[165]	_	_
20-19	3232-3246	gut-associated	abstract[165]	giv[165]	_	_
20-20	3247-3253	immune	abstract|abstract[165]	giv|giv[165]	coref	28-15
20-21	3254-3260	system	abstract[165]	giv[165]	_	_
20-22	3261-3263	in	abstract[165]	giv[165]	_	_
20-23	3264-3272	neonatal	abstract[165]|animal[166]	giv[165]|new[166]	coref	26-41[215_166]
20-24	3273-3279	chicks	abstract[165]|animal[166]	giv[165]|new[166]	_	_
20-25	3280-3281	,	_	_	_	_
20-26	3282-3285	and	_	_	_	_
20-27	3286-3293	thereby	_	_	_	_
20-28	3294-3301	protect	_	_	_	_
20-29	3302-3306	them	abstract	giv	_	_
20-30	3307-3311	from	_	_	_	_
20-31	3312-3319	disease	abstract	giv	coref	22-20[182_0]
20-32	3320-3327	without	_	_	_	_
20-33	3328-3338	decreasing	_	_	_	_
20-34	3339-3345	growth	abstract|abstract[170]	giv|giv[170]	coref|coref|coref|coref	28-25[0_170]|31-21|28-25[0_170]|31-21
20-35	3346-3357	performance	abstract[170]	giv[170]	_	_
20-36	3358-3360	as	_	_	_	_
20-37	3361-3362	a	_	_	_	_
20-38	3363-3371	possible	_	_	_	_
20-39	3372-3384	substitution	_	_	_	_
20-40	3385-3387	of	_	_	_	_
20-41	3388-3399	antibiotics	object	giv	_	_
20-42	3400-3401	.	_	_	_	_

#Text=Prebiotics , which are defined as non-digestible oligosaccharides , are also potent modulators of the intestinal microflora .
21-1	3402-3412	Prebiotics	abstract	new	coref	21-12[173_0]
21-2	3413-3414	,	_	_	_	_
21-3	3415-3420	which	_	_	_	_
21-4	3421-3424	are	_	_	_	_
21-5	3425-3432	defined	_	_	_	_
21-6	3433-3435	as	_	_	_	_
21-7	3436-3450	non-digestible	_	_	_	_
21-8	3451-3467	oligosaccharides	_	_	_	_
21-9	3468-3469	,	_	_	_	_
21-10	3470-3473	are	_	_	_	_
21-11	3474-3478	also	_	_	_	_
21-12	3479-3485	potent	abstract[173]	giv[173]	_	_
21-13	3486-3496	modulators	abstract[173]	giv[173]	_	_
21-14	3497-3499	of	abstract[173]	giv[173]	_	_
21-15	3500-3503	the	abstract[173]|object[174]	giv[173]|new[174]	coref	26-38[214_174]
21-16	3504-3514	intestinal	abstract[173]|object[174]	giv[173]|new[174]	_	_
21-17	3515-3525	microflora	abstract[173]|object[174]	giv[173]|new[174]	_	_
21-18	3526-3527	.	_	_	_	_

#Text=For instance , addition of prebiotic mannanoligosaccharides ( MOS ) to the diet of broilers reduced the severity of the infection due to either E. tenella alone or a mixture of E. acervulina , E. maxima , and E. tenella .
22-1	3528-3531	For	_	_	_	_
22-2	3532-3540	instance	_	_	_	_
22-3	3541-3542	,	_	_	_	_
22-4	3543-3551	addition	abstract[175]	new[175]	_	_
22-5	3552-3554	of	abstract[175]	new[175]	_	_
22-6	3555-3564	prebiotic	abstract[175]|substance|substance[177]	new[175]|new|new[177]	appos|appos	22-9[0_177]|22-9[0_177]
22-7	3565-3587	mannanoligosaccharides	abstract[175]|substance[177]	new[175]|new[177]	_	_
22-8	3588-3589	(	_	_	_	_
22-9	3590-3593	MOS	substance	giv	_	_
22-10	3594-3595	)	_	_	_	_
22-11	3596-3598	to	_	_	_	_
22-12	3599-3602	the	abstract[179]	new[179]	_	_
22-13	3603-3607	diet	abstract[179]	new[179]	_	_
22-14	3608-3610	of	abstract[179]	new[179]	_	_
22-15	3611-3619	broilers	abstract[179]|substance	new[179]|new	_	_
22-16	3620-3627	reduced	_	_	_	_
22-17	3628-3631	the	abstract[181]	new[181]	_	_
22-18	3632-3640	severity	abstract[181]	new[181]	_	_
22-19	3641-3643	of	abstract[181]	new[181]	_	_
22-20	3644-3647	the	abstract[181]|abstract[182]	new[181]|giv[182]	coref	31-37[273_182]
22-21	3648-3657	infection	abstract[181]|abstract[182]	new[181]|giv[182]	_	_
22-22	3658-3661	due	_	_	_	_
22-23	3662-3664	to	_	_	_	_
22-24	3665-3671	either	_	_	_	_
22-25	3672-3674	E.	_	_	_	_
22-26	3675-3682	tenella	_	_	_	_
22-27	3683-3688	alone	_	_	_	_
22-28	3689-3691	or	_	_	_	_
22-29	3692-3693	a	substance[183]	new[183]	_	_
22-30	3694-3701	mixture	substance[183]	new[183]	_	_
22-31	3702-3704	of	substance[183]	new[183]	_	_
22-32	3705-3707	E.	substance[183]	new[183]	_	_
22-33	3708-3718	acervulina	substance[183]	new[183]	_	_
22-34	3719-3720	,	substance[183]	new[183]	_	_
22-35	3721-3723	E.	substance[183]	new[183]	_	_
22-36	3724-3730	maxima	substance[183]	new[183]	_	_
22-37	3731-3732	,	substance[183]	new[183]	_	_
22-38	3733-3736	and	substance[183]	new[183]	_	_
22-39	3737-3739	E.	substance[183]	new[183]	_	_
22-40	3740-3747	tenella	substance[183]	new[183]	_	_
22-41	3748-3749	.	_	_	_	_

#Text=However , for the bioactives to be effective , these compounds have to be administered to the animals under fully controlled conditions and as early as possible .
23-1	3750-3757	However	_	_	_	_
23-2	3758-3759	,	_	_	_	_
23-3	3760-3763	for	_	_	_	_
23-4	3764-3767	the	substance[184]	new[184]	_	_
23-5	3768-3778	bioactives	substance[184]	new[184]	_	_
23-6	3779-3781	to	substance[184]	new[184]	_	_
23-7	3782-3784	be	substance[184]	new[184]	_	_
23-8	3785-3794	effective	substance[184]	new[184]	_	_
23-9	3795-3796	,	_	_	_	_
23-10	3797-3802	these	object[185]	new[185]	_	_
23-11	3803-3812	compounds	object[185]	new[185]	_	_
23-12	3813-3817	have	_	_	_	_
23-13	3818-3820	to	_	_	_	_
23-14	3821-3823	be	_	_	_	_
23-15	3824-3836	administered	_	_	_	_
23-16	3837-3839	to	_	_	_	_
23-17	3840-3843	the	animal[186]	giv[186]	_	_
23-18	3844-3851	animals	animal[186]	giv[186]	_	_
23-19	3852-3857	under	_	_	_	_
23-20	3858-3863	fully	abstract[187]	new[187]	coref	29-15[244_187]
23-21	3864-3874	controlled	abstract[187]	new[187]	_	_
23-22	3875-3885	conditions	abstract[187]	new[187]	_	_
23-23	3886-3889	and	_	_	_	_
23-24	3890-3892	as	_	_	_	_
23-25	3893-3898	early	_	_	_	_
23-26	3899-3901	as	_	_	_	_
23-27	3902-3910	possible	_	_	_	_
23-28	3911-3912	.	_	_	_	_

#Text=An innovative method for introducing bioactive substances into chickens is the in ovo injection into eggs intended for hatching .
24-1	3913-3915	An	abstract[188]	new[188]	ana	25-1[0_188]
24-2	3916-3926	innovative	abstract[188]	new[188]	_	_
24-3	3927-3933	method	abstract[188]	new[188]	_	_
24-4	3934-3937	for	_	_	_	_
24-5	3938-3949	introducing	_	_	_	_
24-6	3950-3959	bioactive	substance[189]	new[189]	coref	25-19[199_189]
24-7	3960-3970	substances	substance[189]	new[189]	_	_
24-8	3971-3975	into	_	_	_	_
24-9	3976-3984	chickens	animal	giv	coref	29-24[246_0]
24-10	3985-3987	is	_	_	_	_
24-11	3988-3991	the	event[192]	new[192]	coref	27-13[219_192]
24-12	3992-3994	in	event[192]	new[192]	_	_
24-13	3995-3998	ovo	object|event[192]	new|new[192]	coref	27-13
24-14	3999-4008	injection	event[192]	new[192]	_	_
24-15	4009-4013	into	event[192]	new[192]	_	_
24-16	4014-4018	eggs	event[192]|object	new[192]|new	_	_
24-17	4019-4027	intended	_	_	_	_
24-18	4028-4031	for	_	_	_	_
24-19	4032-4040	hatching	_	_	_	_
24-20	4041-4042	.	_	_	_	_

#Text=This is a technique that is based on the introduction on the appropriate day of embryonic development of bioactive substances into the air chamber of the egg or directly into the developing embryo .
25-1	4043-4047	This	abstract	giv	coref	25-3[195_0]
25-2	4048-4050	is	_	_	_	_
25-3	4051-4052	a	abstract[195]	giv[195]	coref	26-1[204_195]
25-4	4053-4062	technique	abstract[195]	giv[195]	_	_
25-5	4063-4067	that	_	_	_	_
25-6	4068-4070	is	_	_	_	_
25-7	4071-4076	based	_	_	_	_
25-8	4077-4079	on	_	_	_	_
25-9	4080-4083	the	event[196]	new[196]	_	_
25-10	4084-4096	introduction	event[196]	new[196]	_	_
25-11	4097-4099	on	event[196]	new[196]	_	_
25-12	4100-4103	the	event[196]|time[197]	new[196]|new[197]	_	_
25-13	4104-4115	appropriate	event[196]|time[197]	new[196]|new[197]	_	_
25-14	4116-4119	day	event[196]|time[197]	new[196]|new[197]	_	_
25-15	4120-4122	of	event[196]|time[197]	new[196]|new[197]	_	_
25-16	4123-4132	embryonic	event[196]|time[197]|event[198]	new[196]|new[197]|new[198]	coref	26-22[0_198]
25-17	4133-4144	development	event[196]|time[197]|event[198]	new[196]|new[197]|new[198]	_	_
25-18	4145-4147	of	event[196]|time[197]|event[198]	new[196]|new[197]|new[198]	_	_
25-19	4148-4157	bioactive	event[196]|time[197]|event[198]|substance[199]	new[196]|new[197]|new[198]|giv[199]	_	_
25-20	4158-4168	substances	event[196]|time[197]|event[198]|substance[199]	new[196]|new[197]|new[198]|giv[199]	_	_
25-21	4169-4173	into	event[196]|time[197]|event[198]	new[196]|new[197]|new[198]	_	_
25-22	4174-4177	the	event[196]|time[197]|event[198]|place[201]	new[196]|new[197]|new[198]|new[201]	_	_
25-23	4178-4181	air	event[196]|time[197]|event[198]|abstract|place[201]	new[196]|new[197]|new[198]|new|new[201]	coref	27-21
25-24	4182-4189	chamber	event[196]|time[197]|event[198]|place[201]	new[196]|new[197]|new[198]|new[201]	_	_
25-25	4190-4192	of	event[196]|time[197]|event[198]|place[201]	new[196]|new[197]|new[198]|new[201]	_	_
25-26	4193-4196	the	event[196]|time[197]|event[198]|place[201]|object[202]	new[196]|new[197]|new[198]|new[201]|new[202]	coref	26-11[206_202]
25-27	4197-4200	egg	event[196]|time[197]|event[198]|place[201]|object[202]	new[196]|new[197]|new[198]|new[201]|new[202]	_	_
25-28	4201-4203	or	_	_	_	_
25-29	4204-4212	directly	object[203]	new[203]	_	_
25-30	4213-4217	into	object[203]	new[203]	_	_
25-31	4218-4221	the	object[203]	new[203]	_	_
25-32	4222-4232	developing	object[203]	new[203]	_	_
25-33	4233-4239	embryo	object[203]	new[203]	_	_
25-34	4240-4241	.	_	_	_	_

#Text=This method allows for a precise and uniform delivery of the bioactive substance to all embryos at an early stage of development , which unifies the effects of prebiotics across the flock and ensures proper development of gut microflora in all chicks .
26-1	4242-4246	This	abstract[204]	giv[204]	_	_
26-2	4247-4253	method	abstract[204]	giv[204]	_	_
26-3	4254-4260	allows	_	_	_	_
26-4	4261-4264	for	_	_	_	_
26-5	4265-4266	a	abstract[205]	new[205]	_	_
26-6	4267-4274	precise	abstract[205]	new[205]	_	_
26-7	4275-4278	and	abstract[205]	new[205]	_	_
26-8	4279-4286	uniform	abstract[205]	new[205]	_	_
26-9	4287-4295	delivery	abstract[205]	new[205]	_	_
26-10	4296-4298	of	abstract[205]	new[205]	_	_
26-11	4299-4302	the	abstract[205]|object[206]	new[205]|giv[206]	coref	27-26[0_206]
26-12	4303-4312	bioactive	abstract[205]|object[206]	new[205]|giv[206]	_	_
26-13	4313-4322	substance	abstract[205]|object[206]	new[205]|giv[206]	_	_
26-14	4323-4325	to	abstract[205]|object[206]	new[205]|giv[206]	_	_
26-15	4326-4329	all	abstract[205]|object[206]|animal[207]	new[205]|giv[206]|new[207]	_	_
26-16	4330-4337	embryos	abstract[205]|object[206]|animal[207]	new[205]|giv[206]|new[207]	_	_
26-17	4338-4340	at	abstract[205]	new[205]	_	_
26-18	4341-4343	an	abstract[205]|abstract[208]	new[205]|new[208]	_	_
26-19	4344-4349	early	abstract[205]|abstract[208]	new[205]|new[208]	_	_
26-20	4350-4355	stage	abstract[205]|abstract[208]	new[205]|new[208]	_	_
26-21	4356-4358	of	abstract[205]|abstract[208]	new[205]|new[208]	_	_
26-22	4359-4370	development	abstract[205]|abstract[208]|event	new[205]|new[208]|giv	_	_
26-23	4371-4372	,	_	_	_	_
26-24	4373-4378	which	_	_	_	_
26-25	4379-4386	unifies	_	_	_	_
26-26	4387-4390	the	abstract[210]	new[210]	coref	28-1[230_210]
26-27	4391-4398	effects	abstract[210]	new[210]	_	_
26-28	4399-4401	of	abstract[210]	new[210]	_	_
26-29	4402-4412	prebiotics	abstract[210]|substance[211]	new[210]|new[211]	coref	27-16[220_211]
26-30	4413-4419	across	abstract[210]|substance[211]	new[210]|new[211]	_	_
26-31	4420-4423	the	abstract[210]|substance[211]|animal[212]	new[210]|new[211]|new[212]	_	_
26-32	4424-4429	flock	abstract[210]|substance[211]|animal[212]	new[210]|new[211]|new[212]	_	_
26-33	4430-4433	and	_	_	_	_
26-34	4434-4441	ensures	_	_	_	_
26-35	4442-4448	proper	event[213]	new[213]	_	_
26-36	4449-4460	development	event[213]	new[213]	_	_
26-37	4461-4463	of	event[213]	new[213]	_	_
26-38	4464-4467	gut	event[213]|object[214]	new[213]|giv[214]	_	_
26-39	4468-4478	microflora	event[213]|object[214]	new[213]|giv[214]	_	_
26-40	4479-4481	in	event[213]|object[214]	new[213]|giv[214]	_	_
26-41	4482-4485	all	event[213]|object[214]|animal[215]	new[213]|giv[214]|giv[215]	_	_
26-42	4486-4492	chicks	event[213]|object[214]|animal[215]	new[213]|giv[214]|giv[215]	_	_
26-43	4493-4494	.	_	_	_	_

#Text=Studies conducted in the temperate climatic condition have already revealed that in ovo injection of prebiotics and probiotics into the air cell during embryogenesis improves egg hatchability and modulate the optimal composition of the chicken â€™s microbiota , fully developed at hatching .
27-1	4495-4502	Studies	event	new	_	_
27-2	4503-4512	conducted	_	_	_	_
27-3	4513-4515	in	_	_	_	_
27-4	4516-4519	the	abstract[217]	new[217]	_	_
27-5	4520-4529	temperate	abstract[217]	new[217]	_	_
27-6	4530-4538	climatic	abstract[217]	new[217]	_	_
27-7	4539-4548	condition	abstract[217]	new[217]	_	_
27-8	4549-4553	have	_	_	_	_
27-9	4554-4561	already	_	_	_	_
27-10	4562-4570	revealed	_	_	_	_
27-11	4571-4575	that	_	_	_	_
27-12	4576-4578	in	_	_	_	_
27-13	4579-4582	ovo	object|event[219]	giv|giv[219]	coref|coref	29-7|29-7
27-14	4583-4592	injection	event[219]	giv[219]	_	_
27-15	4593-4595	of	event[219]	giv[219]	_	_
27-16	4596-4606	prebiotics	event[219]|substance[220]	giv[219]|giv[220]	coref	29-9[0_220]
27-17	4607-4610	and	event[219]|substance[220]	giv[219]|giv[220]	_	_
27-18	4611-4621	probiotics	event[219]|substance[220]|substance	giv[219]|giv[220]|new	_	_
27-19	4622-4626	into	event[219]	giv[219]	_	_
27-20	4627-4630	the	event[219]|place[223]	giv[219]|new[223]	_	_
27-21	4631-4634	air	event[219]|place|place[223]	giv[219]|giv|new[223]	_	_
27-22	4635-4639	cell	event[219]|place[223]	giv[219]|new[223]	_	_
27-23	4640-4646	during	event[219]|place[223]	giv[219]|new[223]	_	_
27-24	4647-4660	embryogenesis	event[219]|place[223]|event	giv[219]|new[223]|new	_	_
27-25	4661-4669	improves	_	_	_	_
27-26	4670-4673	egg	object|event[226]	giv|new[226]	_	_
27-27	4674-4686	hatchability	event[226]	new[226]	_	_
27-28	4687-4690	and	_	_	_	_
27-29	4691-4699	modulate	_	_	_	_
27-30	4700-4703	the	abstract[227]	new[227]	_	_
27-31	4704-4711	optimal	abstract[227]	new[227]	_	_
27-32	4712-4723	composition	abstract[227]	new[227]	_	_
27-33	4724-4726	of	abstract[227]	new[227]	_	_
27-34	4727-4730	the	abstract[227]|abstract[229]	new[227]|giv[229]	_	_
27-35	4731-4738	chicken	abstract[227]|animal[228]|abstract[229]	new[227]|new[228]|giv[229]	coref	28-8[231_228]
27-36	4739-4741	â€™s	abstract[227]|animal[228]|abstract[229]	new[227]|new[228]|giv[229]	_	_
27-37	4742-4752	microbiota	abstract[227]|abstract[229]	new[227]|giv[229]	_	_
27-38	4753-4754	,	_	_	_	_
27-39	4755-4760	fully	_	_	_	_
27-40	4761-4770	developed	_	_	_	_
27-41	4771-4773	at	_	_	_	_
27-42	4774-4782	hatching	_	_	_	_
27-43	4783-4784	.	_	_	_	_

#Text=These effects are reportedly stable throughout the chicken â€™s lifespan , influencing metabolic and immune responses of the host , resulting in improvement in performance and meat quality .
28-1	4785-4790	These	abstract[230]	giv[230]	_	_
28-2	4791-4798	effects	abstract[230]	giv[230]	_	_
28-3	4799-4802	are	_	_	_	_
28-4	4803-4813	reportedly	_	_	_	_
28-5	4814-4820	stable	_	_	_	_
28-6	4821-4831	throughout	_	_	_	_
28-7	4832-4835	the	abstract[232]	new[232]	_	_
28-8	4836-4843	chicken	animal[231]|abstract[232]	giv[231]|new[232]	_	_
28-9	4844-4846	â€™s	animal[231]|abstract[232]	giv[231]|new[232]	_	_
28-10	4847-4855	lifespan	abstract[232]	new[232]	_	_
28-11	4856-4857	,	_	_	_	_
28-12	4858-4869	influencing	_	_	_	_
28-13	4870-4879	metabolic	abstract	new	_	_
28-14	4880-4883	and	_	_	_	_
28-15	4884-4890	immune	abstract|abstract[235]	giv|new[235]	_	_
28-16	4891-4900	responses	abstract[235]	new[235]	_	_
28-17	4901-4903	of	abstract[235]	new[235]	_	_
28-18	4904-4907	the	abstract[235]|animal[236]	new[235]|giv[236]	_	_
28-19	4908-4912	host	abstract[235]|animal[236]	new[235]|giv[236]	_	_
28-20	4913-4914	,	_	_	_	_
28-21	4915-4924	resulting	_	_	_	_
28-22	4925-4927	in	_	_	_	_
28-23	4928-4939	improvement	abstract[237]	new[237]	_	_
28-24	4940-4942	in	abstract[237]	new[237]	_	_
28-25	4943-4954	performance	abstract[237]|abstract	new[237]|giv	coref	31-21[265_0]
28-26	4955-4958	and	abstract[237]	new[237]	_	_
28-27	4959-4963	meat	abstract[237]|substance|abstract[240]	new[237]|new|giv[240]	coref|coref|coref|coref	29-24|31-27[269_240]|29-24|31-27[269_240]
28-28	4964-4971	quality	abstract[237]|abstract[240]	new[237]|giv[240]	_	_
28-29	4972-4973	.	_	_	_	_

#Text=However , the efficacy of in ovo delivered prebiotics has been evaluated mainly under fully controlled disease-free experimental conditions in the temperate using meat type chickens .
29-1	4974-4981	However	_	_	_	_
29-2	4982-4983	,	_	_	_	_
29-3	4984-4987	the	abstract[241]	giv[241]	coref	31-3[258_241]
29-4	4988-4996	efficacy	abstract[241]	giv[241]	_	_
29-5	4997-4999	of	abstract[241]	giv[241]	_	_
29-6	5000-5002	in	abstract[241]	giv[241]	_	_
29-7	5003-5006	ovo	abstract[241]|abstract	giv[241]|giv	ana	30-5
29-8	5007-5016	delivered	_	_	_	_
29-9	5017-5027	prebiotics	substance	giv	coref	30-9
29-10	5028-5031	has	_	_	_	_
29-11	5032-5036	been	_	_	_	_
29-12	5037-5046	evaluated	_	_	_	_
29-13	5047-5053	mainly	_	_	_	_
29-14	5054-5059	under	_	_	_	_
29-15	5060-5065	fully	abstract[244]	giv[244]	coref	30-13[251_244]
29-16	5066-5076	controlled	abstract[244]	giv[244]	_	_
29-17	5077-5089	disease-free	abstract[244]	giv[244]	_	_
29-18	5090-5102	experimental	abstract[244]	giv[244]	_	_
29-19	5103-5113	conditions	abstract[244]	giv[244]	_	_
29-20	5114-5116	in	abstract[244]	giv[244]	_	_
29-21	5117-5120	the	abstract[244]	giv[244]	_	_
29-22	5121-5130	temperate	abstract[244]	giv[244]	_	_
29-23	5131-5136	using	_	_	_	_
29-24	5137-5141	meat	substance|animal[246]	giv|giv[246]	coref|coref|coref|coref	31-27|31-44[275_246]|31-27|31-44[275_246]
29-25	5142-5146	type	animal[246]	giv[246]	_	_
29-26	5147-5155	chickens	animal[246]	giv[246]	_	_
29-27	5156-5157	.	_	_	_	_

#Text=In this study , it was hypothesized that prebiotics perform differently under field conditions in the tropics where management and environmental factors predispose birds to enteric diseases .
30-1	5158-5160	In	_	_	_	_
30-2	5161-5165	this	abstract[247]	new[247]	_	_
30-3	5166-5171	study	abstract[247]	new[247]	_	_
30-4	5172-5173	,	_	_	_	_
30-5	5174-5176	it	abstract	giv	coref	31-7
30-6	5177-5180	was	_	_	_	_
30-7	5181-5193	hypothesized	_	_	_	_
30-8	5194-5198	that	_	_	_	_
30-9	5199-5209	prebiotics	substance	giv	coref	31-9[260_0]
30-10	5210-5217	perform	_	_	_	_
30-11	5218-5229	differently	_	_	_	_
30-12	5230-5235	under	_	_	_	_
30-13	5236-5241	field	place|abstract[251]	new|giv[251]	coref|coref	31-48[276_251]|31-48[276_251]
30-14	5242-5252	conditions	abstract[251]	giv[251]	_	_
30-15	5253-5255	in	abstract[251]	giv[251]	_	_
30-16	5256-5259	the	abstract[251]|place[252]	giv[251]|new[252]	_	_
30-17	5260-5267	tropics	abstract[251]|place[252]	giv[251]|new[252]	_	_
30-18	5268-5273	where	_	_	_	_
30-19	5274-5284	management	organization	new	_	_
30-20	5285-5288	and	_	_	_	_
30-21	5289-5302	environmental	abstract[254]	new[254]	_	_
30-22	5303-5310	factors	abstract[254]	new[254]	_	_
30-23	5311-5321	predispose	_	_	_	_
30-24	5322-5327	birds	animal[255]	new[255]	_	_
30-25	5328-5330	to	animal[255]	new[255]	_	_
30-26	5331-5338	enteric	animal[255]|object|abstract[257]	new[255]|new|new[257]	_	_
30-27	5339-5347	diseases	animal[255]|abstract[257]	new[255]|new[257]	_	_
30-28	5348-5349	.	_	_	_	_

#Text=Thus , the efficacy of in ovo delivered prebiotics , antibiotic-chick formula , and a combination of the two on growth performance , carcass traits , meat quality , and gut health in the face of a natural coccidiosis infection was assessed in Kuroiler chickens reared under field conditions in Uganda .
31-1	5350-5354	Thus	_	_	_	_
31-2	5355-5356	,	_	_	_	_
31-3	5357-5360	the	abstract[258]	giv[258]	_	_
31-4	5361-5369	efficacy	abstract[258]	giv[258]	_	_
31-5	5370-5372	of	abstract[258]	giv[258]	_	_
31-6	5373-5375	in	abstract[258]	giv[258]	_	_
31-7	5376-5379	ovo	abstract[258]|animal	giv[258]|giv	_	_
31-8	5380-5389	delivered	_	_	_	_
31-9	5390-5400	prebiotics	substance[260]	giv[260]	_	_
31-10	5401-5402	,	substance[260]	giv[260]	_	_
31-11	5403-5419	antibiotic-chick	substance[260]|substance[261]	giv[260]|new[261]	_	_
31-12	5420-5427	formula	substance[260]|substance[261]	giv[260]|new[261]	_	_
31-13	5428-5429	,	substance[260]	giv[260]	_	_
31-14	5430-5433	and	substance[260]	giv[260]	_	_
31-15	5434-5435	a	substance[260]|abstract[262]	giv[260]|new[262]	_	_
31-16	5436-5447	combination	substance[260]|abstract[262]	giv[260]|new[262]	_	_
31-17	5448-5450	of	substance[260]|abstract[262]	giv[260]|new[262]	_	_
31-18	5451-5454	the	substance[260]|abstract[262]|abstract[263]	giv[260]|new[262]|new[263]	_	_
31-19	5455-5458	two	substance[260]|abstract[262]|abstract[263]	giv[260]|new[262]|new[263]	_	_
31-20	5459-5461	on	substance[260]|abstract[262]|abstract[263]	giv[260]|new[262]|new[263]	_	_
31-21	5462-5468	growth	substance[260]|abstract[262]|abstract[263]|abstract|abstract[265]	giv[260]|new[262]|new[263]|giv|giv[265]	_	_
31-22	5469-5480	performance	substance[260]|abstract[262]|abstract[263]|abstract[265]	giv[260]|new[262]|new[263]|giv[265]	_	_
31-23	5481-5482	,	substance[260]|abstract[262]|abstract[263]	giv[260]|new[262]|new[263]	_	_
31-24	5483-5490	carcass	substance[260]|abstract[262]|abstract[263]|object|abstract[267]	giv[260]|new[262]|new[263]|new|giv[267]	_	_
31-25	5491-5497	traits	substance[260]|abstract[262]|abstract[263]|abstract[267]	giv[260]|new[262]|new[263]|giv[267]	_	_
31-26	5498-5499	,	substance[260]|abstract[262]|abstract[263]	giv[260]|new[262]|new[263]	_	_
31-27	5500-5504	meat	substance[260]|abstract[262]|abstract[263]|substance|abstract[269]	giv[260]|new[262]|new[263]|giv|giv[269]	_	_
31-28	5505-5512	quality	substance[260]|abstract[262]|abstract[263]|abstract[269]	giv[260]|new[262]|new[263]|giv[269]	_	_
31-29	5513-5514	,	substance[260]|abstract[262]|abstract[263]	giv[260]|new[262]|new[263]	_	_
31-30	5515-5518	and	substance[260]|abstract[262]|abstract[263]	giv[260]|new[262]|new[263]	_	_
31-31	5519-5522	gut	substance[260]|abstract[262]|abstract[263]|abstract|abstract[271]	giv[260]|new[262]|new[263]|giv|giv[271]	_	_
31-32	5523-5529	health	substance[260]|abstract[262]|abstract[263]|abstract[271]	giv[260]|new[262]|new[263]|giv[271]	_	_
31-33	5530-5532	in	substance[260]|abstract[262]|abstract[263]|abstract[271]	giv[260]|new[262]|new[263]|giv[271]	_	_
31-34	5533-5536	the	substance[260]|abstract[262]|abstract[263]|abstract[271]|abstract[272]	giv[260]|new[262]|new[263]|giv[271]|new[272]	_	_
31-35	5537-5541	face	substance[260]|abstract[262]|abstract[263]|abstract[271]|abstract[272]	giv[260]|new[262]|new[263]|giv[271]|new[272]	_	_
31-36	5542-5544	of	substance[260]|abstract[262]|abstract[263]|abstract[271]|abstract[272]	giv[260]|new[262]|new[263]|giv[271]|new[272]	_	_
31-37	5545-5546	a	substance[260]|abstract[262]|abstract[263]|abstract[271]|abstract[272]|abstract[273]	giv[260]|new[262]|new[263]|giv[271]|new[272]|giv[273]	_	_
31-38	5547-5554	natural	substance[260]|abstract[262]|abstract[263]|abstract[271]|abstract[272]|abstract[273]	giv[260]|new[262]|new[263]|giv[271]|new[272]|giv[273]	_	_
31-39	5555-5566	coccidiosis	substance[260]|abstract[262]|abstract[263]|abstract[271]|abstract[272]|abstract[273]	giv[260]|new[262]|new[263]|giv[271]|new[272]|giv[273]	_	_
31-40	5567-5576	infection	substance[260]|abstract[262]|abstract[263]|abstract[271]|abstract[272]|abstract[273]	giv[260]|new[262]|new[263]|giv[271]|new[272]|giv[273]	_	_
31-41	5577-5580	was	_	_	_	_
31-42	5581-5589	assessed	_	_	_	_
31-43	5590-5592	in	_	_	_	_
31-44	5593-5601	Kuroiler	object|animal[275]	new|giv[275]	_	_
31-45	5602-5610	chickens	animal[275]	giv[275]	_	_
31-46	5611-5617	reared	_	_	_	_
31-47	5618-5623	under	_	_	_	_
31-48	5624-5629	field	abstract[276]	giv[276]	_	_
31-49	5630-5640	conditions	abstract[276]	giv[276]	_	_
31-50	5641-5643	in	abstract[276]	giv[276]	_	_
31-51	5644-5650	Uganda	abstract[276]|place	giv[276]|giv	_	_
31-52	5651-5652	.	_	_	_	_
